Other — Total revenues
Gilead Sciences Other — Total revenues decreased by 32.6% to $58.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 17.1%, from $70.00M to $58.00M. Over 3 years (FY 2022 to FY 2025), Other — Total revenues shows a downward trend with a -13.6% CAGR.
Analysis
How to read this metric
An increase suggests successful monetization of secondary assets or stable demand for legacy products, while a decrease may indicate product sunsetting or a strategic shift away from these non-core areas.
Detailed definition
This metric represents the aggregate gross revenue generated from products or services that fall outside the company's p...
Peer comparison
Peers often report this as 'Other Products' or 'Non-Core Revenue,' and it typically represents a small, declining portion of total revenue as companies focus on high-growth therapeutic areas.
gild_segment_other_total_revenuesHistorical Data
| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $112.25M | $112.25M | $112.25M | $112.25M | $91.75M | $91.75M | $91.75M | $91.75M | $80.00M | $130.00M | $71.00M | $75.00M | $70.00M | $73.00M | $61.00M | $86.00M | $58.00M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | -18.3% | +0.0% | +0.0% | +0.0% | -12.8% | +62.5% | -45.4% | +5.6% | -6.7% | +4.3% | -16.4% | +41.0% | -32.6% |
| YoY Change | — | — | — | — | -18.3% | -18.3% | -18.3% | -18.3% | -12.8% | +41.7% | -22.6% | -18.3% | -12.5% | -43.8% | -14.1% | +14.7% | -17.1% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Gilead Sciences's other — total revenues?
- Gilead Sciences (GILD) reported other — total revenues of $58.00M in Q1 2026.
- How has Gilead Sciences's other — total revenues changed year-over-year?
- Gilead Sciences's other — total revenues decreased by 17.1% year-over-year, from $70.00M to $58.00M.
- What is the long-term trend for Gilead Sciences's other — total revenues?
- Over 3 years (2022 to 2025), Gilead Sciences's other — total revenues has grown at a -13.6% compound annual growth rate (CAGR), from $449.00M to $290.00M.
- What does other — total revenues mean?
- The total sales revenue generated by the company's secondary or non-core product lines.